Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

  1. Ledermann, J.A.
  2. Embleton-Thirsk, A.C.
  3. Perren, T.J.
  4. Jayson, G.C.
  5. Rustin, G.J.S.
  6. Kaye, S.B.
  7. Hirte, H.
  8. Oza, A.
  9. Vaughan, M.
  10. Friedlander, M.
  11. González-Martín, A.
  12. Deane, E.
  13. Popoola, B.
  14. Farrelly, L.
  15. Swart, A.M.
  16. Kaplan, R.S.
  17. Parmar, M.K.B.
Journal:
ESMO Open

ISSN: 2059-7029

Year of publication: 2021

Volume: 6

Issue: 2

Type: Article

DOI: 10.1016/J.ESMOOP.2020.100043 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus